Experienced in Cavernous Lymphangioma

Melvin D'anastasi

Munich, BY, DE 
Experienced in Cavernous Lymphangioma
Munich, BY, DE 
OverviewLocationsClinical Research

Overview

Melvin D'anastasi practices in Munich, Germany. Mr. D'anastasi is rated as an Experienced expert by MediFind in the treatment of Cavernous Lymphangioma. His top areas of expertise are Scrotal Masses, Cavernous Lymphangioma, Colorectal Cancer, Splenomegaly, and Prostatectomy.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cavernous Lymphangioma.

Gender
Male

Locations

Munich, BY 81377, Germany
Other Locations
Heinz, BY, Germany
Forchheim, BY, Germany
Bayern, BY 81377, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Prospective, Multicenter, Randomized, Controlled Study Evaluating SIR-Spheres Y-90 Resin Microspheres Preceding Cisplatin-gemcitabine (CIS-GEM) Chemotherapy Versus CIS-GEM Chemotherapy Alone as First-line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: May 09, 2025
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3

78 Total Publications

European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies.
European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological malignancies.
Journal: HemaSphere
Published: October 28, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. D'anastasi's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile